Alan Bash
Vermögen: 178 105 $ am 31.08.2026
Vermögen: 178 105 $ am 31.08.2026
Mr. Alan S.
Bash is a President-Carvykti at Legend Biotech Corp.
Mr. Bash was previously employed as a Chief Executive Officer & Director by ZielBio, Inc., a President & Chief Executive Officer by Checkmate Pharmaceuticals, Inc., and a Senior Vice President-Commercial Model Innovation by Bristol Myers Squibb Co. He received his undergraduate degree from Georgetown University and an MBA from Columbia Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0,01 % | 14.08.2026 | 17.142 ( 0,01 % ) | 178 105 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Corporate Officer/Principal | 15.09.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Vorstandsvorsitzender | 01.10.2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| CHECKMATE PHARMACEUTICALS, INC. | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen